Strasbourg, France · Founded 2017 · Privately Held (backing)
Developer of a peptide-based drug designed to offer treatment for patients suffering from type 2 diabetes. AdipoPharma is based in Strasbourg, France and was founded in 2017. Its last known valuation is $18.4 million. It has raised $34.5 million.
Last price · $/share
—
Implied valuation
$18.4M
Total raised
$34.5M
Last round
—
Cap table — not yet on record
AdipoPharma's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of AdipoPharma with a free account
·The complete investor list: 11 names
·Watch AdipoPharma: the Monday email on marks, rounds and moves
